申请人:Board of Regents, The University of Texas System
公开号:US20160002204A1
公开(公告)日:2016-01-07
Disclosed herein are compounds and compositions useful in the treatment of GLS1 mediated diseases, such as cancer, having the structure of Formula I:
Methods of inhibition GLS1 activity in a human or animal subject are also provided.
本文披露了一些具有I式结构的化合物和组合物,可用于治疗GLS1介导的疾病,例如癌症。同时,还提供了抑制人类或动物主体中GLS1活性的方法。